1. Home
  2. GRFS vs TMHC Comparison

GRFS vs TMHC Comparison

Compare GRFS & TMHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.84

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Taylor Morrison Home Corporation

TMHC

Taylor Morrison Home Corporation

HOLD

Current Price

$59.20

Market Cap

6.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
TMHC
Founded
1940
1936
Country
Spain
United States
Employees
25247
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.0B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
GRFS
TMHC
Price
$7.84
$59.20
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
$10.15
$78.75
AVG Volume (30 Days)
682.6K
1.0M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
1.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
7.77
Revenue
N/A
$4,762,059,000.00
Revenue This Year
$5.33
N/A
Revenue Next Year
$6.50
$9.07
P/E Ratio
$18.67
$7.58
Revenue Growth
N/A
N/A
52 Week Low
$6.19
$51.90
52 Week High
$11.14
$72.27

Technical Indicators

Market Signals
Indicator
GRFS
TMHC
Relative Strength Index (RSI) 27.72 30.58
Support Level $7.64 $57.56
Resistance Level $9.11 $60.69
Average True Range (ATR) 0.29 1.64
MACD -0.12 -0.80
Stochastic Oscillator 2.99 10.34

Price Performance

Historical Comparison
GRFS
TMHC

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About TMHC Taylor Morrison Home Corporation

Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds, and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West, and Financial Services. The majority of the company's revenue is derived from its West Segment.

Share on Social Networks: